Fresenius Medical Care AG (FMS)
21.72
+0.84
(+4.00%)
USD |
NYSE |
May 10, 16:00
21.72
0.00 (0.00%)
After-Hours: 18:41
Fresenius Medical Care Enterprise Value: 20.62B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 20.62B |
| May 08, 2024 | 20.50B |
| May 07, 2024 | 20.17B |
| May 06, 2024 | 20.94B |
| May 03, 2024 | 20.67B |
| May 02, 2024 | 21.08B |
| May 01, 2024 | 20.82B |
| April 30, 2024 | 20.71B |
| April 29, 2024 | 20.52B |
| April 26, 2024 | 20.16B |
| April 25, 2024 | 20.23B |
| April 24, 2024 | 20.55B |
| April 23, 2024 | 20.97B |
| April 22, 2024 | 20.43B |
| April 19, 2024 | 19.83B |
| April 18, 2024 | 19.75B |
| April 17, 2024 | 19.50B |
| April 16, 2024 | 19.28B |
| April 15, 2024 | 19.38B |
| April 12, 2024 | 19.16B |
| April 11, 2024 | 19.48B |
| April 10, 2024 | 19.56B |
| April 09, 2024 | 19.66B |
| April 08, 2024 | 19.46B |
| April 05, 2024 | 19.37B |
| Date | Value |
|---|---|
| April 04, 2024 | 19.36B |
| April 03, 2024 | 19.42B |
| April 02, 2024 | 19.38B |
| April 01, 2024 | 19.57B |
| March 31, 2024 | 19.68B |
| March 28, 2024 | 19.68B |
| March 27, 2024 | 19.73B |
| March 26, 2024 | 19.47B |
| March 25, 2024 | 19.47B |
| March 22, 2024 | 19.37B |
| March 21, 2024 | 19.55B |
| March 20, 2024 | 19.91B |
| March 19, 2024 | 19.83B |
| March 18, 2024 | 19.54B |
| March 15, 2024 | 19.54B |
| March 14, 2024 | 19.89B |
| March 13, 2024 | 20.15B |
| March 12, 2024 | 20.18B |
| March 11, 2024 | 20.15B |
| March 08, 2024 | 20.31B |
| March 07, 2024 | 20.49B |
| March 06, 2024 | 20.13B |
| March 05, 2024 | 20.55B |
| March 04, 2024 | 19.32B |
| March 01, 2024 | 19.73B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.64B
Minimum
Oct 10 2022
37.33B
Maximum
Jul 29 2020
27.72B
Average
29.50B
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -3.223M |
| NuCana PLC | -14.54M |
| TC BioPharm (Holdings) PLC | 0.7929M |
| DaVita Inc | 22.58B |
| Bicycle Therapeutics PLC | 470.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 77.08M |
| Revenue (Quarterly) | 5.132B |
| Total Expenses (Quarterly) | 4.739B |
| EPS Diluted (Quarterly) | 0.1303 |
| Gross Profit Margin (Quarterly) | 24.84% |
| Profit Margin (Quarterly) | 1.50% |
| Earnings Yield | 4.12% |
| Operating Earnings Yield | 14.07% |
| Normalized Earnings Yield | 5.336 |